Nephrocare Health IPO: Price Band, Key Dates, Lot Size & Investor Breakdown Explained

The buzz around the Nephrocare Health IPO has picked up fast, especially after the company locked in its IPO price band at ₹438–₹460 per share. With fresh capital plans, a large network of dialysis centres, and a structured issue reserved for different investor categories, the offering is drawing steady attention in the primary market.

And as someone who tracks market sentiment daily at Samco Securities, this IPO story stood out for its clear numbers, clean structure, and the scale Nephrocare brings to India’s dialysis ecosystem.

Market Performance Snapshot

Investors often look for clarity first—dates, numbers, and structure. The Nephrocare Health IPO keeps it simple.

Nephrocare Health IPO Key Numbers

• Price Band: ₹438–₹460 per equity share (face value: ₹2)
• Subscription Window: Opens December 10, closes December 12
• Anchor Allocation: Scheduled for December 9
• Lot Size: 32 shares, and multiples of 32
• Floor Price: 219× face value
• Cap Price: 230× face value

The reservation split follows a familiar structure:

• QIBs: Not more than 50%
• NIIs: Not less than 15%
• Retail: Not less than 35%

The employee quota includes equity shares worth ₹35 million.

Main News: Issue Size, Allotment Dates & Listing Timeline

Nephrocare Health is set to roll out a ₹353.4 crore IPO, structured as a mix of a fresh issue of shares along with an Offer for Sale (OFS) from existing shareholders.

IPO Structure

• Fresh Issue: ₹353.4 crore
• OFS: 1.12 crore shares offloaded by existing shareholders

From the fresh capital:

• ₹129.1 crore will be directed toward setting up new dialysis clinics across India
• ₹136 crore is earmarked for debt repayment
• The remaining funds go toward general corporate purposes.

Allotment & Listing Timeline

• Basis of Allotment: December 15
• Refund Initiation: December 16
• Demat Credit: December 16
• Listing on BSE & NSE: December 17

Every date is tightly packed—something that typically keeps retail participants alert and engaged.

Company Details: Scale, Presence & Financial Snapshot

Nephrocare Health (NephroPlus) has built one of India’s widest dialysis networks, and its scale adds weight to the numbers in the IPO.

Network & Reach

• 519 clinics globally as of September 30, 2025
• Operates across India — and maintains an international footprint including clinics in the Philippines, Uzbekistan, and Nepal.
• Clinics are spread across 288 cities, covering 21 states and 4 union territories.
• 77% of centres located in Tier II and Tier III cities—highlighting depth beyond metros

International Expansion

• Made its entry into the Kingdom of Saudi Arabia via a joint venture in FY24.
• Operates a 165-bed dialysis facility in Tashkent, the largest of its kind worldwide

Financial Performance (FY25)

• Revenue: ₹756 crore
• Profit After Tax: ₹67 crore

The numbers underline why the IPO is gaining traction among diversified investor pools—Nephrocare operates a large-scale, deeply entrenched healthcare model.

Summary

The Nephrocare Health IPO brings together a broad network footprint, steady financial performance, and a clearly structured issue. With a price band of ₹438–₹460, a mix of fresh issue and OFS, and key dates running from December 9 to December 17, the offering is set to be one of the most-watched listings this month.